Abstract:The nucleosome remodeling and deacetylase (NuRD) complex plays a pivotal role in chromatin regulation and transcriptional repression. In mice, methyl-CpG binding domain 3 isoform C (MBD3C) interacts specifically with the histone H3 binding protein WD repeat-containing protein 5 (WDR5) and forms the WDR5-MBD3C/NuRD complex. Despite the functional significance of this interaction on embryonic stem cells gene regulation, the molecular mechanism underlying MBD3C recognition by WDR5 remains elusive. Here, we determined the crystal structure of WDR5 in complex with the peptide (residues 40-51) derived from the MBD3C protein at a resolution of 1.9 Å. Structural analysis revealed that MBD3C utilizes a unique binding mode to interact with WDR5, wherein MBD3C Arg43 and Phe47 are involved in recognizing the WDR5-interacting (WIN) site and Tyr191-related B site on the small surface of WDR5, respectively. Notably, the binding induces a ∼91° rotation of WDR5 Tyr191, generating the hydrophobic B site. Furthermore, mutation experiments combined with isothermal titration calorimetry (ITC) assays confirmed the importance of both Arg43 and Phe47 in mediating WDR5 binding affinity. By determining structures of various peptides bound to WDR5, we demonstrated that the WDR5 WIN site and B site can be concurrently recognized by WIN motif peptides containing ′′Arg-Cys/Ser-Arg-Val-Phe′′ consensus sequence. Overall, this study reveals the structural basis for the formation of the WDR5-MBD3C subcomplex and provides new insights into the recognition mode of WDR5 for the WIN motif. Moreover, these findings shed light on structural-based designs of WDR5-targeted anti-cancer small molecule inhibitors or peptide-mimic drugs.

Identification and Validation of WDR5 WIN-site Ligands Via DNA-encoded Chemical Library Screening

Discovery and Optimization of WDR5 Inhibitors via Cascade Deoxyribonucleic Acid-Encoded Library Selection Approach

Phage-Display Based Discovery and Characterization of Peptide Ligands against WDR5

Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models

A resource to enable chemical biology and drug discovery of WDR Proteins

Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective

Screening and Optimization of Phage Display Cyclic Peptides Against the WDR5 WBM Site

Design, Synthesis, and Initial Evaluation of Affinity-Based Small Molecular Probe for Detection of WDR5.

Structural Studies of WDR5 in Complex with MBD3C WIN Motif Reveal a Unique Binding Mode

Computational Studies of Novel Aniline Pyrimidine WDR5-MLL1 Inhibitors: QSAR, Molecular Docking, and Molecular Dynamics Simulation

A Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins

Identification of isoform/domain-selective fragments from the selection of DNA-encoded dynamic library

Protein-templated Ligand Discovery Via the Selection of DNA-encoded Dynamic Libraries

WIN site inhibition disrupts a subset of WDR5 function

ABPP-CoDEL: Activity-Based Proteome Profiling-Guided Discovery of Tyrosine-Targeting Covalent Inhibitors from DNA-Encoded Libraries

Identification of Pyrroloimidazoles As Potential Inhibitors of WDR5-WIN-Site by 3D-QSAR Molecular Simulation

Selection of DNA‐Encoded Dynamic Chemical Libraries for Direct Inhibitor Discovery

Discovery of DDO-2213 As a Potent and Orally Bioavailable Inhibitor of the WDR5-Mixed Lineage Leukemia 1 Protein-Protein Interaction for the Treatment of MLL Fusion Leukemia

Development of a DNA-encoded library screening method DEL Zipper to empower the study of RNA-targeted chemical matter

Enabling Open Machine Learning of DNA Encoded Library Selections to Accelerate the Discovery of Small Molecule Protein Binders

Chemical Space Profiling of SARS-CoV-2 PL pro Using DNA-Encoded Focused Libraries